Introduction
The term "nutraceutical" is a neologism derived from "nutrition" and "pharmaceutical", coined in 1989 by Stephen De Felice to describe "a food or part of it that determines the overall health benefits, including prevention and/ or treatment of diseases" [1] . Nutraceuticals include many products today. Among these, the most studied for possible positive effects are plant derivatives (herbal) [2] . Pharmaceutical herbal preparations consist of roots, seeds, pollen, bark, or fruit, alone or in combination [2, 3] . Many botanical extracts and herbs, such as ginseng, garlic, onion, etc., have nutraceutical properties [1] . Nutraceuticals may be taken either by introducing functional foods in the diet, in the form of simple or enriched food of a specific active principle, or as food supplements in liquid, tablet, or capsule formulation.
Male infertility is a frequent clinical condition with an estimated prevalence of around 7% of the population [4] . Despite these data, unfortunately, the etiology is not known in about 50% of the cases [5] . Obesity, metabolic syndrome, alcohol abuse, cigarette smoking, and exposure to environmental pollutants appear to play a decisive role in a proportion of infertile patients [6] . In such conditions, a chronic inflammatory process occurs that yields to the increase of seminal concentrations of reactive oxygen species (ROS) [4] [5] [6] . Different substances contained in the main nutraceuticals currently available on the market can interfere with the hypothalamic-pituitary-testicular function, directly with spermatogenesis, the accessory glands of the reproductive tract, or erectile function with potential benefits on hormonal balance, fertility, sexual performance, and prostate health [7] . Their use is very common in men who ask for andrologic consultation and disparate formulations are commercially available through the Web; nevertheless, they contain different components combined, whose purity and titration are still not subject to regulation. The global market of these substances is growing with a turnover of over 30 billion dollars in the US alone [7] .
It is estimated that, in Europe, 6 million pieces/year are sold through e-Commerce [8] , thus inducing the patient to skip medical consultation. The use of "natural" products to improve sexual performance is more common in oriental areas, but it is gaining popularity also in Western countries because of the ease access to these products by the Internet. Despite some natural supplements show great promise in improving andrological disorders, most substances reviewed in this article lack robust scientific evidence of efficacy in humans. In addition, concerns of contamination and adulteration are sufficiently worrisome to suggest caution against recommending routinely dietary supplements for male sexual health unless rigorously controlled.
The aim of this article was to analyze the state of the art regarding the clinical evidence on the effectiveness of nutraceuticals in the treatment of the most important andrological diseases and to have a position statement on their use from the Italian Society of Andrology and Sexual Medicine (SIAMS), the principal scientific society in Italy dealing with these conditions. In particular, three major areas will be covered: fertility, sexuality, and prostatic diseases. Moreover, the most commonly used compounds available will be described and presented in detail.
The task force used the following internationally recognized coding system [9] : (1) "we recommend" indicates a strong recommendation; (2) "we suggest" denotes a weak recommendation. Evidence grading: ØOOO denotes very low quality evidence; ØØOO, low quality; ØØØO, moderate quality; and ØØØØ, high quality.
Fertility Recommendation
1. We recommend not prescribing antioxidants for improving sperm parameters and pregnancy rate in all subjects with sperm abnormalities before a specific diagnostic workup (1 ØØØØ). 2. We suggest the use of antioxidants in patients with idiopathic infertility in the presence of documented abnormal sperm parameters and altered sperm DNA fragmentation (SDF) only after a thorough diagnostic workup (2 ØØOO). 3. We suggest no specific antioxidants and therapeutic regimes for improving sperm parameters and pregnancy rate in patients with idiopathic infertility (2 ØØOO).
Evidence
A beneficial effect of nutraceuticals in the treatment of idiopathic male infertility has been described [1, 10] . Several are the antioxidants commonly used to improve male fertility. Among these, the most used are zinc, folic acid, N-acetylcysteine, coenzyme Q10, vitamins E and C, selenium, carnitines, and pentoxifylline in various dosage and variable combinations [2] . Possible indications and evidence of the main antioxidants commonly used for male infertility treatment are summarized in Table 1 . Oxidative stress (OS) is one of the most important causes of male infertility where lower potential antioxidant semen activity compared to controls is reported [9, 11] . Ascorbic acid (vitamin C) Its administration positively correlates with sperm count and motility [38] , and negatively with sperm DNA fragmentation index [39] Oligo-astheno-teratozoospermia Carnitine Improves concentration, total sperm count, and progressive motility [40] [41] [42] [43] [44] [45] Oligo-astheno-teratozoospermia Carotenoids (lycopene, β-carotene) Improve sperm parameters [46] Oligo-astheno-teratozoospermia Coenzyme Q10 Improves sperm count, motility, and morphology [47] [48] [49] [50] Oligo-astheno-teratozoospermia Myoinositol Improves sperm progressive and total motility and the mitochondrial function; increases the number of sperm recovered after swim-up technique [51] [52] [53] Oligo-astheno-teratozoospermia Glutathione Improves sperm concentration, motility, and morphology [54, 55] Oligo-astheno-teratozoospermia
N-acetyl-cysteine
Improves sperm volume, viscosity [56, 57] and motility. Prevents oxidative DNA damage [13] Oligo-astheno-teratozoospermia α-Tocopherol (vitamin E) Increases sperm motility [58] Oligo-astheno-teratozoospermia ROS can be generated by endogenous or exogenous processes and may damage sperm plasma membranes contributing to altered motility and semen quality [7, 8, 11, 12] . In addition, a meta-analysis showed that seminal levels of ROS are inversely associated with the success of assisted reproductive techniques (ARTs) [13] . SDF can be considered a second-level laboratory parameter that can represent a predictor of male fertility in some clinical conditions (idiopathic infertility, recurrent fetal loss, and repeated ART failure) [6] . This marker of sperm damage underlines faults during chromatin maturation, abortive apoptosis, or oxidative attack by ROS [14] . In addition, it is noteworthy to recall how SDF represents a genomic abnormality that impacts on both natural and assisted fertility [14] and it positively correlates with abortion rate [15] and to the success of ART [16] . In light of this evidence, it is not surprising that a beneficial effect of antioxidants in the treatment of idiopathic male infertility has been described [7] . Two meta-analyses of randomized controlled studies (RCTs) have been performed to evaluate the effectiveness of antioxidant treatment in male infertility [17, 18] . More in detail, the first meta-analysis was based on 34 RCTs (8 produced by Italian research groups), evaluating the effects of antioxidants supplementation on male fertility of about 2900 pairs enrolled in 19 different countries [18] . Three types of comparison were made: antioxidants versus placebo; antioxidants versus no treatment; and antioxidants versus antioxidants (other formulation). The antioxidant administered was vitamin E, vitamin C, vitamin B, l-acetylcarnitine, l-carnitine, pentoxifylline, magnesium, zinc, ethyl-cysteine, N-acetyl-cysteine, docosahexaenoic acid, selenium, or various combinations of them. Live birth rate (LBR) was evaluated by only three RCTs. By metaanalyzing available data, the authors showed that men who were prescribed antioxidants had almost a fivefold increase chance of getting a child when compared to controls [OR = 4.85 (1.92; 12.24); p = 0.0008].
Pregnancy rate (PR) per couple was evaluated by 15 studies including nearly 1000 couples. The PR in couples where the male partner had received treatment with antioxidants was significantly higher than that observed in controls: 16% versus 3% [OR = 4.18 (2.65; 6.59); p < 0.00001]. Separately analyzing the two studies in which the pairs underwent ART, the results did not change.
Later, the same authors carried out an updated metaanalysis dealing with 48 RCTs, including about 4200 infertile men. LBR was available in four RCTs including 277 men. Available data confirmed that the treatment with antioxidants was associated with a significant increased LBR when compared to controls [OR = 4.21 (2.08; 8.51), p < 0.0001]. In addition, similar to what reported in the previous meta-analysis, the use of antioxidants was also associated with an increased clinical PR when compared to placebo or no treatment [OR = 3.43 (1.92; 6.11); p < 0.0001]. However, only 7 RCTs were included in the analysis. Finally, the evidence was not sufficient to evaluate the effect of antioxidants on the risk of miscarriage [17] .
Value
Evidence supporting the use of antioxidants for the treatment of male infertility is of low quality. The task force places a high value when antioxidants are administered in men with idiopathic infertility diagnosed after a thorough diagnostic workup in the presence of abnormal sperm parameters and an altered SDF.
Remarks
Despite the evidence reported above, the more recent Cochrane systematic review observed that most studies currently available were of poor quality and only four are small RCT studies conducted with high-quality criteria [17] . Therefore, it is appropriate to emphasize that the use of antioxidants has to be reserved as empirical treatment for patients with idiopathic infertility after a careful diagnostic workup when other causes are not present or have unsuccessfully been treated with other drugs. SDF evaluation can be of further help in the identification of patients who can have greater benefit from this type of treatment [9] . Although a general agreement on the SDF cut-off does not still exists and different methods are used to evaluate SDF, we suggest that values above 20% could be considered as pathological [6] . A further limitation is the almost complete absence of comparative studies between the various antioxidants and/or combinations between them, as well as the wide variations in the therapeutic regimes adopted and duration of treatments. We cannot, therefore, suggest specific antioxidants, detailed therapeutic regimes, or indicate success rates in terms of improvement in semen parameters and pregnancy.
Sexuality Recommendation
1. We recommend not using nutraceuticals to increase testosterone levels (1 ØØØØ). 2. We recommend against the use of nutraceuticals to improve male sexual desire, erectile function, or ejaculatory reflex as the first-line therapy (1 ØØØO); 3. We suggest the use of yohimbine to improve erectile function in eugonadic men with erectile dysfunction (ED) with predominant psychogenic component in association with sexological therapy (2 ØOOO).
Evidence
Several substances are commonly sold as potential stimulants of the male sexual behavior. The specific analysis of individual preparations is beyond the aim of this review and has already been summarized elsewhere [7] . Table 2 lists the main compounds that alone or in combination are supposed to improve male sexual performance.
The only nutraceutical molecule that has shown some usefulness when compared with placebo in improving ED is yohimbine. This substance acts at the central level by enhancing sexual desire (α 2 -adrenergic receptor blockade and increased locus coeruleus cell firing) and peripherally by limiting the adverse effects of sympatho-adrenergic transmission through postsynaptic α1-adrenergic receptor blockade and enhancement of intra-penile NO levels [19] . A study of inherent meta-analysis of 7 placebo-controlled trials has shown a greater efficacy of yohimbine compared to placebo in improving erectile function [20] . EBM on ED unconvincing
Bergamot (bergamot polyphenolic fraction, BPF) 500-1000 mg Increases NO release, decreases LDL cholesterol [25] Poor EBM in ED, tested in diabetic and dyslipidemic patients only Yohimbine 50-63 mg Neural transmission, peripheral NO increase [20] Clinical efficacy as monotherapy for ED, no comparative study with PDE5i
Tribulus terrestris is ineffective in increasing testosterone levels in humans. In addition, its role in improving sexual function is limited, although recent data from a placebo-controlled trial seem to support a beneficial effect in ED [21, 22] .
The use of DHEAS is associated with a significant increase in circulating testosterone levels when compared to placebo that, nevertheless, is insufficient to improve erectile function and sexual desire [23] .
Panax ginseng is the most common nutraceutical used to improve male sexual function because of its potentiating effect on NO release. A meta-analysis supports its efficacy in improving the male sexual function [24] . However, the methodological quality of the RCTs included in that analysis was poor and the number of studies limited [24] .
Finally, recent evidence has been collected that bergamot polyphenolic fraction (BPF), due to its antioxidant properties, produces an enhancement of NO release from endothelial cells in patients suffering from mixed hyperlipemia and diabetes, thus suggesting that this extract, alone or in combination with other herbal products, may be effective in improving arterial inflow to the penis [25] . However, no RCTs are available.
Value
Evidence supporting the use of antioxidants for the treatment of male sexual dysfunction is very low. The task force places a higher value for yohimbine, but its prescription is limited in some countries including Italy due to the possible risk of adverse events.
Remarks
Testosterone supplementation improves sexual function in men with hypogonadism [26] [27] [28] . Therefore, nutraceuticals could be offered to men with sexual disturbances as the first-line therapy unless medical evaluation has been carried out. Although the use of nutraceuticals to improve male sexual performance is progressively increasing, top market products contain miscellaneous supplemental facts that limit the possibility to support proof of efficacy for any single component in controlled studies. Hyperhomocysteinemia in patients' homozygotes for the C677T mutation may interfere with erection mechanisms and thus be responsible for ED [29] . We recognize that the use of B vitamin and folic acid in patients with hyperhomocysteinemia [30] or in diabetics appears promising, and l-arginine could potentially find a niche for use in patients with endothelial dysfunction or dysregulation of NO synthesis. In addition, Tribulus terrestris appears a promising agent in ameliorating male sexual distress/sexual desire, but overall, its efficacy remains lower than the standard therapy. Maca has been used for male sexual health for decades, but there is limited human evidence in the peer-reviewed literature to support utilization of this product in management of male sexual health [47] . Ginkgo biloba induces NO in endothelial cells and relaxation of vascular smooth muscle cells, and has been proposed to improve the management of ED in men using selective serotonin reuptake inhibitor [4] . However, other studies have failed to show a benefit [7] .
Red Ginseng has been shown to slightly ameliorate erectile function [31] , but the quality of evidence is poor. Yohimbine is one of the few exceptions in this regard in psychogenic ED, but it should be remembered that its prescription is limited in some countries, including Italy, and that there are no studies comparing it to pharmaceutical interventions like PDE5i.
Prostatic diseases Recommendation
1. We recommend not using nutraceuticals as monotherapy for the treatment of low urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) (1 ØØØØ). 2. We suggest to consider the use of nutraceuticals for the treatment of chronic pelvic pain (2 ØOOO). 3. We recommend not using nutraceuticals for the treatment of prostate cancer (1 ØØØØ).
Evidence
A meta-analysis on 18 RCTs including about 1600 patients with BPH compared the effect of treatments with Pygeum africanum (alone or in combination) versus placebo or other BPH medications on LUTS. The study found a twofold increase of the chance of having an improvement in overall symptoms [OR = 2.1 (1.4; 3.1)] in men treated with Pygeum africanum when compared to those taking placebo or other BPH medications. In particular, nocturia decreased by 15%, residual urine volume by 24%, and peak urine flow increased by 23% [32] . However, the reviewed studies were small in size, were of short duration, used varied doses and preparations, and rarely reported outcomes using standardized validated measures of efficacy [32] . Another meta-analysis on two placebo-controlled and two comparative trials (444 patients with BPH) observed a slight improvement of the overall urologic symptoms in men treated with Cernilton/Secale corn [33] . However, similar to what reported for Pygeum africanum, important limitations were present including the short duration of the trials included, the limited number of enrollees, the gaps in
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reported outcomes, and unknown quality of the preparations utilized [33] .
According to the most recent systematic Cochrane review on RCTs, Serenoa repens was not superior to placebo, finasteride, tamsulosin in the improvement of the International Prostatic Symptoms Score (IPSS) [34] . Similar results were reported for urinary flow measures or prostate size [34] . However, it should be recognize that the better evidence has been reported when ethanolic extract preparations have been considered (http:// www.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_ library%2FHerbal_-_Overview_of_comments_received_ during_consultation%2F2016%2F03%2FWC500203898. pdf&usg=AFQjCNFeud5uYNA4VHOuLqKuRkK871K IxA). More recently, an Italian multicentre double blind RCT (the PROCOMB trial) on 225 patients showed that in patients with LUTS, the combined therapy with herbal agents (Serenoa repens, lycopene, and selenium) and tamsulosin were more effective than single molecules in improving the IPSS and in increasing the peak urine flow [35] .
Finally, to better understand the role of antioxidants in the treatment of chronic prostatitis/chronic pelvic pain syndrome, a meta-analysis carried out on 23 RCTs observed the greatest improvement in clinical symptoms score with α-blockers, antibiotics, and combination of these therapies, while other drugs (including phytotherapy) showed a lesser, but measureable effect [36] .
Some studies have reported the use of sulforaphane (isothiocyanate present in cruciferous vegetables), Pomi-T (pomegranate, turmeric, green tea, and broccoli), POMx (pomegranate extract), soybeans, lycopene, and associated with turmeric isoflavones [34, 36] to be associated with a decrease or stabilization of serum PSA levels. However, such studies have been conducted on small cohorts and for short duration. Data from preclinical studies suggest a potential antitumor role of saffron, crocetin, and crocin in prostate cancer. These substances might be effective also in the metastatic process [37] .
The main nutraceuticals investigated in this field are represented by Carotenoids (lycopene and β-carotene), green tea, phytoestrogens, selenium, vitamin E, and Serenoa repens, and their use and evidence are summarized in Table 3 .
Value
There is not enough evidence to recommend the use of nutraceuticals in monotherapy for the treatment of LUTS in patients with BPH and for the treatment of prostate cancer. The task force places a very low value on the benefits of nutraceuticals on chronic pelvic pain.
Remarks
SIAMS endorses the guidelines of EAU [3] in not giving specific recommendations on the use of herbal medicine for the treatment of LUTS due to the heterogeneity of the products, the limited regulatory framework, and methodological limitations of the studies and meta-analysis. It is recognized that the herbal medicine may have some beneficial effects on pain improvement in patients with chronic pelvic pain, but the studies are about too limited to draw definitive conclusions [3] .
Despite the current data should recommend a diet low in fat, rich in fruits and vegetables, and avoiding high caloric intake, there is no definitive evidence that supports a specific therapeutic or supplementary diet to reduce the risk of prostate disease.
Conclusions
Although there is some evidence suggesting a possible role of nutraceuticals in andrology and sexual medicine, we recognize that scientific evidence of available data is limited. The use of antioxidants can be suggested in patients with idiopathic infertility in the presence of documented [72, 73] Possible role in the prevention of prostate cancer Phytoestrogens Physiological concentrations of isoflavones are capable to under-regulate androgen receptor of prostate tumor cells and to inhibit 5α-reductase and aromatase enzymes [72] Possible role in the prevention of prostate cancer
Serenoa repens
Anti-inflammatory effects on prostate tissue [35, 74] Benign prostate hyperplasia abnormal sperm parameters and altered SDF after an adequate diagnostic workup. Conversely, the evidence suggesting a role of nutraceuticals in the treatment of sexual dysfunction and prostate diseases is more limited and needs to be addressed in randomized controlled trials.
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